Molecular Medicine Ireland research portfolio comprises a broad range of genomic, proteomic and transcriptomic-based investigations undertaken by research teams across our constituent partner institutions. In addition Molecular Medicine Ireland has recognised the need for involvement in biobanking initiatives at national and international level. To this end we are coordinating the preparatory phase of an all-island control biobank for Ireland and actively participating in the preparatory phase of a pan-European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) network.

The Molecular Medicine Ireland research portfolio can be summarised as investigations into four principal disease areas and the development of enabling resources and technologies.